Inovio Pharmaceuticals
INO
#8898
Rank
S$0.18 B
Marketcap
S$2.68
Share price
2.48%
Change (1 day)
-52.04%
Change (1 year)

Earnings for Inovio Pharmaceuticals (INO)

Earnings in 2025 (TTM): -S$0.15 Billion

According to Inovio Pharmaceuticals's latest financial reports the company's current earnings are S$0.18 Million. In 2024 the company made an earning of -S$0.14 Billion, an increase over its 2023 earnings that were of -S$0.18 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Inovio Pharmaceuticals from 1999 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -S$0.15 Billion1.89%
2024 -S$0.14 Billion-20.03%
2023 -S$0.18 Billion-51.56%
2022 -S$0.36 Billion-8.26%
2021 -S$0.4 Billion95.4%
2020 -S$0.2 Billion36.62%
2019 -S$0.15 Billion20.19%
2018 -S$0.13 Billion10.94%
2017 -S$0.11 Billion9.59%
2016 -S$0.11 Billion118.9%
2015 -S$45.73 Million-10.67%
2014 -S$51.19 Million83.32%
2013 -S$27.92 Million
2011 -S$28.81 Million15.64%
2010 -S$24.91 Million37.7%
2009 -S$18.09 Million2.19%
2008 -S$17.71 Million-14.09%
2007 -S$20.61 Million19.12%
2006 -S$17.3 Million9.62%
2005 -S$15.78 Million5.77%
2004 -S$14.92 Million73.08%
2003 -S$8.62 Million12.75%
2002 -S$7.65 Million
2000 -S$11.57 Million53.93%
1999 -S$7.52 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Pfizer
PFE
S$15.35 B-11,064.73%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
S$41.98 B-30,070.77%๐Ÿ‡บ๐Ÿ‡ธ USA
Arrowhead Pharmaceuticals
ARWR
-S$97.29 Million-30.55%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
S$21.27 B-15,289.84%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Merck
MRK
S$29.92 B-21,461.43%๐Ÿ‡บ๐Ÿ‡ธ USA
GlaxoSmithKline
GSK
S$12.08 B-8,724.97%๐Ÿ‡ฌ๐Ÿ‡ง UK
Gilead Sciences
GILD
S$12.81 B-9,245.91%๐Ÿ‡บ๐Ÿ‡ธ USA
Cleveland BioLabs
CBLI
-S$3.57 Million-97.45%๐Ÿ‡บ๐Ÿ‡ธ USA